| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 10/07/1997 | US5674884 For treatment of serotonin-related disorders |
| 10/07/1997 | US5674834 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 10/07/1997 | US5674708 Amino acid at position 358 is selected from the group consisting of isoleucine, valine, alanine, aspartic acid, threonine and glutamic acid |
| 10/07/1997 | CA2041380C Use of protein c or activated protein c for preparing a pharmaceutical preparation |
| 10/02/1997 | WO1997035864A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin |
| 10/02/1997 | WO1997035854A1 Novel phenanthridines substituted in the 6 position |
| 10/02/1997 | WO1997035849A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation |
| 10/02/1997 | WO1997035616A1 Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 10/02/1997 | WO1997035601A1 TREATMENT OF CYSTIC DISEASE WITH TNF-$g(a) |
| 10/02/1997 | WO1997035591A2 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 10/02/1997 | WO1997035572A1 Carboxylic acid indole inhibitors of chemokines |
| 10/02/1997 | CA2250403A1 Treatment of cystic disease with tnf-a |
| 10/02/1997 | CA2249999A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation |
| 10/01/1997 | EP0797988A2 Anti-angiogenic compositions and methods of use |
| 10/01/1997 | EP0797435A1 Controlled release matrix for pharmaceuticals |
| 09/30/1997 | US5672595 Method of controlling male fertility |
| 09/27/1997 | CA2201088A1 Use of .alpha.1 -adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia |
| 09/25/1997 | WO1997034924A1 Process and intermediates for the synthesis of lhrh antagonists |
| 09/25/1997 | WO1997034899A1 Heterocyclic compounds and their preparation and use |
| 09/25/1997 | CA2248153A1 Heterocyclic compounds and their preparation and use |
| 09/24/1997 | EP0796855A1 Inhibitors of bone resorption and vitronectin receptor antagonists |
| 09/24/1997 | EP0796342A2 Genetic basis of factor xiii activity |
| 09/24/1997 | EP0796322A1 Production and use of human and plant methyltransferases |
| 09/24/1997 | EP0796270A2 Peptide compounds for prevention and/or treatment of no-mediated diseases |
| 09/24/1997 | EP0796251A1 Uracil derivatives |
| 09/24/1997 | EP0796250A1 Pyridazinones as endothelin-receptor antagonists |
| 09/24/1997 | EP0796243A1 Diaminocyclobutene-3,4-diones |
| 09/24/1997 | EP0796109A1 Antisense oligonucleotides to suppress eicosanoid formation |
| 09/24/1997 | EP0491708B1 Isolating aminoarginine and use to block nitric oxide formation in body |
| 09/24/1997 | CN1160396A Carboxylic acid derivs., their preparation and their use |
| 09/24/1997 | CN1160347A Use of indole drivs. for treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways desease, glaucoma and ocular. |
| 09/24/1997 | CN1160042A Ortho-substd. benzoyl guanidines, their preparing process and use as medicine and diagnostic reagent, and medicine contg. same |
| 09/23/1997 | US5670516 Excitatory amino acid receptor antagonists |
| 09/23/1997 | US5670512 Skin disorders; reductase inhibitors |
| 09/23/1997 | US5670504 2,6-diaryl pyridazinones with immunosuppressant activity |
| 09/23/1997 | US5670501 Useful as diuretics, treating renal disorders, restoring cardiac functions |
| 09/23/1997 | US5670499 Physiological disorders, gastrointestinal disorders, antiinflammatory agents |
| 09/23/1997 | US5670176 Dialysis solution |
| 09/20/1997 | CA2199923A1 Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 09/18/1997 | WO1997033912A2 Uses of gdnf and gdnf receptor |
| 09/18/1997 | WO1997033883A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 09/18/1997 | WO1997033880A1 Methods of treating or preventing interstitial cystitis |
| 09/18/1997 | WO1997033873A1 Methods of treating or preventing interstitial cystitis |
| 09/18/1997 | WO1997033583A1 Methods of treating or preventing interstitial cystitis |
| 09/18/1997 | CA2250288A1 Methods of treating or preventing interstitial cystitis |
| 09/18/1997 | CA2248013A1 Methods of treating or preventing interstitial cystitis |
| 09/18/1997 | CA2247822A1 Methods of treating or preventing interstitial cystitis |
| 09/18/1997 | CA2246768A1 Uses of gdnf and gdnf receptor |
| 09/17/1997 | EP0794794A1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 09/17/1997 | EP0698022B1 1,4-benzoxazine derivatives as potassium channel openers |
| 09/17/1997 | CN1159805A Nvel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 09/17/1997 | CN1159804A Dihydrobenzofuranes |
| 09/17/1997 | CN1159760A Enteral vaccine for vaginal infections |
| 09/17/1997 | CN1159444A Sulfuryl amino substituted benzoyl guanidine, preparation process and applications as medicine or diagnostic agent and the medicine containing same |
| 09/16/1997 | US5668180 Alkoxyaryl compounds |
| 09/16/1997 | US5668158 Cyclic amino acid derivatives |
| 09/16/1997 | US5668157 Cyanoguanidines as K-channel blockers |
| 09/16/1997 | US5668148 Benign prostatic hypertrophy |
| 09/16/1997 | US5668139 Xanthine derivatives |
| 09/16/1997 | US5668137 N-heterocyclic sulfonamides having endothelin receptor activity |
| 09/16/1997 | US5668115 Hydrolyzates of colominic acid |
| 09/12/1997 | WO1997032874A1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 09/12/1997 | WO1997032849A1 Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors |
| 09/12/1997 | WO1997032575A1 Mercapto derivatives as inhibitors of cyclooxygenases |
| 09/12/1997 | CA2248188A1 Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors |
| 09/12/1997 | CA2248187A1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 09/10/1997 | EP0794172A1 Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
| 09/10/1997 | EP0793961A1 Use of droloxifene for the manufacture of a medicament for increasing serum levels of testosterone |
| 09/10/1997 | EP0793498A1 Bicyclic heterocyclic compounds for the treatment of impotence |
| 09/10/1997 | EP0793492A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
| 09/10/1997 | EP0793486A1 cGMP-PDE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION |
| 09/09/1997 | US5665758 6-Heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles |
| 09/09/1997 | US5665743 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles |
| 09/04/1997 | WO1997031941A2 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | WO1997031895A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/04/1997 | WO1997031654A1 Nitric oxide donors capable of reducing toxicity from drugs |
| 09/04/1997 | WO1997031637A1 Use of 5-ht1a receptor antagonists for the treatment of urinary incontinence |
| 09/04/1997 | WO1997031636A1 Novel indole and benzothiazole derivatives |
| 09/04/1997 | WO1997031634A1 At1 receptor antagonist for the stimulation of apoptosis |
| 09/04/1997 | CA2247802A1 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | CA2247208A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/04/1997 | CA2246813A1 Novel indole and benzothiazole derivatives |
| 09/04/1997 | CA2198980A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/03/1997 | EP0792643A1 Use of an aldose reductase inhibitor for reducing non-cardiac tissue damage |
| 09/03/1997 | EP0792642A1 Method of treating conditions with estrogen agonists |
| 09/03/1997 | EP0792641A1 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 09/03/1997 | EP0792640A2 Use of (E)-1-(4'-(2-alkylaminoethioxy)-phenyl)-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes for inhibiting pathological conditions |
| 09/03/1997 | EP0792292A2 Orphan receptor |
| 09/03/1997 | EP0792168A1 Novel tumor suppressor gene, hic-1 |
| 09/03/1997 | EP0792162A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 09/03/1997 | EP0687256B1 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions |
| 09/03/1997 | EP0656905B1 Calcium channel blocking polypeptide from agelenopsis aperta |
| 09/03/1997 | CN1158613A Novel use and noveld erivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 09/03/1997 | CN1158606A Benzoylaguanidine derivatives as medicaments |
| 09/02/1997 | US5663450 Promotes healing |
| 09/02/1997 | US5663347 Regulators of cell proliferation and differentiation; treatment of skin disorders; anticarcinognic agents |
| 09/02/1997 | US5663191 Psychiatric diseases, anxiety and antidepressants |
| 09/02/1997 | US5663174 Antiinflammatory agents, inhibitor of kinases, antiarthritic agents |
| 09/02/1997 | US5663173 Central nervous system disorders, cognition activators, pychoses, antidepressants and eating disorders |
| 08/28/1997 | WO1997030656A1 Male contraceptive implant |